Open AccessUnusual trigger for dermatomyositis: Atorvastatin
Author(s) -
P. K. Abeysundera,
M. D. S. A. Dilrukshi,
Nilanga Nishad,
G. M. O. Fernando,
I. Atukorale
Publication year - 2018
Publication title -
journal of the ceylon college of physicians
Language(s) - English
Resource type - Journals
ISSN - 2448-9514
DOI - 10.4038/jccp.v49i1.7846
Subject(s) - ceylon , medicine , audience measurement , sri lanka , medical journal , alternative medicine , family medicine , multidisciplinary approach , medical education , socioeconomics , social science , political science , law , programming language , sociology , pathology , computer science , tanzania
Malignancies, infections and rarely drugs have been identified as the trigger for dermatomyositis which presents with proximal muscle weakness, myalgia and photosensitive skin rashes1. HMG-CoA reductase inhibitors or statins are frequently prescribed for primary and secondary prevention of atherosclerotic cardiovascular disease. Derangement of liver enzymes and myotoxocity is commonly encountered following treatment with statins but association with dermatomyositis is indistinct.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom